BK polyomavirus program (Orthogon Therapeutics)

N/A

Report date: 2025/01/26 18:51:59
NME

Base Information

Drug NameBK polyomavirus program (Orthogon Therapeutics)
Drug Alias Namesmall molecule therapeutics (Orthogon Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsBK Polyomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrthogon Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesOrthogon Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsBK Polyomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A